Literature DB >> 11531259

ALA- and ALA-hexylester-induced protoporphyrin IX fluorescence and distribution in multicell tumour spheroids.

C E Bigelow1, S Mitra, R Knuechel, T H Foster.   

Abstract

Synthesis of protoporphyrin IX (PpIX) in intact murine mammary cancer cell spheroids is reported from optical sections obtained using a laser scanning confocal fluorescence microscope. EMT6 spheroids 275-350 microm in diameter were incubated in 0.1-15 mM aminolevulinic acid (ALA) or 0.001-2 mM ALA-hexylester (h-ALA) to test the ability of both pro-drugs to diffuse into the spheroids and induce PpIX production. Spheroids incubated with ALA show significant fluorescence nonuniformity for all concentrations, with the outermost cells exhibiting greater porphyrin fluorescence. Comparable levels of fluorescence throughout the optical section are achieved with approximately 100-fold lower h-ALA concentrations, indicating that the interior cells maintain esterase activity and porphyrin synthesis and that h-ALA diffuses efficiently to the spheroid interior. Fluorescence gradients are less pronounced with h-ALA incubation, in part because of apparent saturation of esterase activity in the spheroid perimeter. Proliferating (Ki67 positive) and quiescent cell populations exhibit remarkably different h-ALA concentration dependencies. The incubation concentration resulting in maximum fluorescence with ALA is 10 mM, while the optimal concentration for h-ALA is 200-fold lower at 0.05 mM. Exceeding these optimal concentrations for both pro-drugs leads to an overall loss of fluorescence. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11531259      PMCID: PMC2364128          DOI: 10.1054/bjoc.2001.1977

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

Review 1.  The Ki-67 protein: from the known and the unknown.

Authors:  T Scholzen; J Gerdes
Journal:  J Cell Physiol       Date:  2000-03       Impact factor: 6.384

2.  Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin.

Authors:  Q Peng; J Moan; T Warloe; V Iani; H B Steen; A Bjørseth; J M Nesland
Journal:  J Photochem Photobiol B       Date:  1996-06       Impact factor: 6.252

Review 3.  5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research.

Authors:  Q Peng; K Berg; J Moan; M Kongshaug; J M Nesland
Journal:  Photochem Photobiol       Date:  1997-02       Impact factor: 3.421

4.  5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells.

Authors:  P Uehlinger; M Zellweger; G Wagnières; L Juillerat-Jeanneret; H van den Bergh; N Lange
Journal:  J Photochem Photobiol B       Date:  2000-01       Impact factor: 6.252

5.  Fluence rate effects in photodynamic therapy of multicell tumor spheroids.

Authors:  T H Foster; D F Hartley; M G Nichols; R Hilf
Journal:  Cancer Res       Date:  1993-03-15       Impact factor: 12.701

6.  Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin.

Authors:  J Kloek; W Akkermans; G M Beijersbergen van Henegouwen
Journal:  Photochem Photobiol       Date:  1998-01       Impact factor: 3.421

7.  Prodrugs of 5-aminolevulinic acid for photodynamic therapy.

Authors:  J Kloek
Journal:  Photochem Photobiol       Date:  1996-12       Impact factor: 3.421

8.  Oxygen diffusion and reaction kinetics in the photodynamic therapy of multicell tumour spheroids.

Authors:  M G Nichols; T H Foster
Journal:  Phys Med Biol       Date:  1994-12       Impact factor: 3.609

9.  Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX.

Authors:  L Wyld; J L Burn; M W Reed; N J Brown
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro.

Authors:  L Wyld; M W Reed; N J Brown
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

View more
  11 in total

1.  Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids.

Authors:  Steen J Madsen; Chung-Ho Sun; Bruce J Tromberg; Henry Hirschberg
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

2.  Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model.

Authors:  Jonathan P Celli; Imran Rizvi; Conor L Evans; Adnan O Abu-Yousif; Tayyaba Hasan
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

3.  Toward a 3D cellular model for studying in vitro the outcome of photodynamic treatments: accounting for the effects of tissue complexity.

Authors:  Mireia Alemany-Ribes; María García-Díaz; Marta Busom; Santi Nonell; Carlos E Semino
Journal:  Tissue Eng Part A       Date:  2013-04-19       Impact factor: 3.845

4.  Acute morphological sequelae of photodynamic therapy with 5-aminolevulinic acid in the C6 spheroid model.

Authors:  Pitr Zelenkov; Reinhold Baumgartner; Karl Bise; Michael Heide; Richard Meier; Susanne Stocker; Ronald Sroka; Roland Goldbrunner; Walter Stummer
Journal:  J Neurooncol       Date:  2006-09-27       Impact factor: 4.130

5.  Spatiotemporal Tracking of Different Cell Populations in Cancer Organoid Models for Investigations on Photodynamic Therapy.

Authors:  Anne-Laure Bulin; Tayyaba Hasan
Journal:  Methods Mol Biol       Date:  2022

6.  ALA- and ALA-ester-mediated photodynamic therapy of human glioma spheroids.

Authors:  Henry Hirschberg; Chung-Ho Sun; Bruce J Tromberg; Steen J Madsen
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

7.  PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model.

Authors:  Imran Rizvi; Sriram Anbil; Nermina Alagic; Jonathan Celli; Jonathan P Celli; Lei Zak Zheng; Akilan Palanisami; Michael D Glidden; Brian W Pogue; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2013-04-04       Impact factor: 3.421

8.  The effects of ultra low fluence rate single and repetitive photodynamic therapy on glioma spheroids.

Authors:  Marlon S Mathews; Even Angell-Petersen; Rogelio Sanchez; Chung-Ho Sun; Van Vo; Henry Hirschberg; Steen J Madsen
Journal:  Lasers Surg Med       Date:  2009-10       Impact factor: 4.025

9.  Low-cost photodynamic therapy devices for global health settings: Characterization of battery-powered LED performance and smartphone imaging in 3D tumor models.

Authors:  Joshua Hempstead; Dustin P Jones; Abdelali Ziouche; Gwendolyn M Cramer; Imran Rizvi; Stephen Arnason; Tayyaba Hasan; Jonathan P Celli
Journal:  Sci Rep       Date:  2015-05-12       Impact factor: 4.379

10.  Derivatives of 5-aminolevulinic Acid for photodynamic therapy.

Authors:  Ryan F Donnelly; Paul A McCarron; A David Woolfson
Journal:  Perspect Medicin Chem       Date:  2007-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.